View PDF
Pfizer, Bristol-Myers Squibb snag radio partner for 'Tune in to AFib' awareness push | Fierce Pharma
P&U with Pfizer Bristol-Myers Squibb for "Atrial Fibrillation" - Polk & Union
Bristol-Myers Squibb-Pfizer Alliance, Fitbit collaborate on Afib and stroke
L'alliance BMS-Pfizer et l'association France AVC dévoilent une collection de vidéos pour informer les patients victimes
Pfizer: nouvelles données sur les anti-coagulants
Bristol Myers Squibb/Pfizer Alliance Independent Medical Education/Global Medical Grants
Bristol-Myers Squibb-Pfizer Alliance, Fitbit Team Up on Atrial Fibrillation Detection | DAIC
Bristol-Myers-Squibb met 13 milliards de dollars pour s'offrir une biotech en cardiologie | Les Echos
Bristol Myers Squibb et Pfizer s'engagent pour sensibiliser à la fibrillation atriale (FA)
Partnership tra Bristol-Myers Squibb-Pfizer Alliance e Fitbit sulla fibrillazione atriale • NCF - Notiziario Chimico Farmaceutico
Bristol Myers Squibb Company - ESG News & Media
BMS and Pfizer to donate $1m for cardiovascular education - PMLiVE
Alliance BMS/Pfizer - Agir pour le coeur des femmes
Bristol-Myers Squibb - Pfizer Alliance ACROPOLIS™ real-world data program grows to sample size of nearly one million lives worldwide
Un engagement historique contre les maladies du cœur
Moments matter in Pfizer and Bristol-Myers Squibb's latest pitch for afib awareness | Fierce Pharma
Fitbit collaborating with pharma giants Bristol-Myers Squibb and Pfizer | Fierce Healthcare
Le patient anticoagulé au cœur de la Réunion de Concertation Pluridisciplinaire Vasculaire
The Bristol-Myers Squibb-Pfizer Alliance welcomes the decision by the U.S. Court of Appeals for the Federal Circuit upholding the Eliquis Patents - Medical Update Online
Bristol-Myers Squibb and Pfizer Announce Randomized, Controlled Trial to Evaluate the Effect of Atrial Fibrillation Screening on Health Outcomes in Older Individuals | Business Wire
BMS-Pfizer : ECTH2023
L'Alliance Bristol Myers Squibb - Pfizer lance #LaFAnAttendPas, un programme pour co-imaginer des solutions innovantes face aux risques de la Fibrillation Atriale
ESC: New Pfizer, BMS real-world data could boost Eliquis in Europe | Fierce Pharma
The Bristol-Myers Squibb-Pfizer Alliance and Fitbit Collaborate to Address Gaps in Atrial Fibrillation Detection with the Aim of Accelerating Diagnosis | Business Wire
AHA and BMS/Pfizer: Identifying undiagnosed, asymptomatic AFib - Center for Health Technology & Innovation
